Topiramate for weight reduction in Duchenne muscular dystrophy

Muscle and Nerve

Volumn 31, Issue 6, 2005, Pages 788-789

  Carter, Gregory T ^a   Yudkowsky, Michelle P ^a   Han, Jay J ^a   McCrory, Megan A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; TOPIRAMATE;

ADOLESCENT; CALORIC INTAKE; CASE REPORT; CONCENTRATION LOSS; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DUCHENNE MUSCULAR DYSTROPHY; FATIGUE; HUMAN; LETTER; MALE; OBESITY; PARESTHESIA; PRIORITY JOURNAL; SOMNOLENCE; UPPER RESPIRATORY TRACT INFECTION; WEIGHT REDUCTION;

ADOLESCENT; ANTI-OBESITY AGENTS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; APPETITE; BODY WEIGHT; BUPROPION; CALORIC RESTRICTION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FRUCTOSE; HUMANS; MALE; MUSCULAR DYSTROPHY, DUCHENNE; OBESITY; TREATMENT OUTCOME;

EID: 19544379331     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.20321     Document Type: Letter

References (8)

1. Astrup A, Caterson I, Zelissen P, Guy-Grand B, Carruba M, Levy B, et al. Topiramate: long-term maintenance of weight loss induced by a low-calorie diet in obese subjects. Obes Res 2004;12:1658-1669.
2. Bray GA, Hollander P, Klein S, Kushner R, Levy B, Fitchet M, et al. A 6-month randomized, placebo-controlled, dose-ranging trial of topiramate for weight loss in obesity. Obes Res 2003;6:722-733.
3. Edwards RHT, Round JM, Jackson MJ. Weight reduction in boys with muscular dystrophy. Dev Med Child Neurol 1984;26:384-390.
4. Gadde KM, Parker CB, Maner LG, Wagner HR II, Logue EJ, Drezner MK, et al. Buproprion for weight loss: an investigation of efficacy and tolerability in overweight and obese women. Obes Res 2001;9:544-551.
5. Kanda F, Fujii Y, Takahashi K, Fujita T. Dual-energy x-ray absorptiometry in neuromuscular diseases. Muscle Nerve 1994;17:431-435.
6. McCrory M, Wright N, Kilmer D. Nutritional aspects of neuromuscular diseases. Phys Med Rehabil Clin N Am 1998;9:127-136.
7. Palmieri GM, Bertorini TE, Griffin JW, Igarashi M, Karas JG. Assessment of whole body composition with dual energy x-ray absorptiometry in Duchenne muscular dystrophy: correlation of lean body mass with muscle function. Muscle Nerve 1996;19:777-779.
8. Wilding J, Van Gaal L, Rissanen A, Vercruysse F, Fitchet M. OBES-002 Study Group. A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects. Int J Obes Relat Metab Disord 2004;28:1399-1410.